Reistone Biopharma Company Limited clinical trials

A subsidiary of Jiangsu HengRui Medicine Co., Ltd.

The registry lists 16 studies whose lead sponsor is Reistone Biopharma Company Limited. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 17, 2026.

Studies

Recruiting first, then most recently updated. Showing 16 of 16. All Jiangsu HengRui Medicine Co., Ltd. studies →

• Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 TabletNot yet recruitingNCT07696091Phase 1

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary DiseaseRecruitingNCT07349524Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.Not yet recruitingNCT07543224Phase 3

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative ColitisRecruitingNCT05181137Phase 3

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Clinical Study of RSS0343 in Healthy SubjectsCompletedNCT07289464Phase 1

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic DermatitisCompletedNCT07158151Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic DermatitisActive, not recruitingNCT04717310Phase 2/3

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia AreataActive, not recruitingNCT05470413Phase 3

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous NephropathyActive, not recruitingNCT05136456Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.CompletedNCT03675477Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT04875169Phase 3

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Phase II Study in Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT04162899Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• An Open Label Study of the Effects of SHR1459 in NMOSDs PatientsCompletedNCT04670770Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Phase II Study in Patients With Moderate to Severe Active Crohn's DiseaseCompletedNCT03677648Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With VitiligoTerminatedNCT04774809Phase 2/3

  Sponsor listed in the registry: Reistone Biopharma Company Limited

• A Phase II Study in Patients With Alopecia AreataCompletedNCT04346316Phase 2

  Sponsor listed in the registry: Reistone Biopharma Company Limited